Background
Methods
Patients/study participants
HDV antibody screening
HDV RNA isolation, quantification and short fragment amplification
HDV full genome amplification and sequencing
Phylogenetic and sequence analysis
Statistical analysis
Results
Patients/Clients
Study groups | Lab. Code | Age/sex | Virological characteristics | Clinical characteristics | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Anti-HCV | HIV status | HBV viral load | HBeAg | HBV genotype | HDV viral load | HDV genotype | ||||
HIV co-infected |
ETH3790
|
34/M
|
Neg
|
Pos
|
3.62
|
Neg
a
|
A1
|
9.67 × 10
6
|
I
|
WHO stage I
|
ETH2170
|
36/F
|
Pos
|
Pos
|
Un
|
Pos
|
–
|
2.27 × 10
5
|
I
|
WHO stage IV
| |
ETH2280
|
33/M
|
Neg
|
Pos
|
Un
|
Neg
|
–
|
7.08 × 10
7
|
I
|
WHO stage I
| |
ETH1480 | 37/F | Neg | Pos | 2.72 | Neg | D2 | – | – | WHO stage II | |
ETH1570 | 57/F | Neg | Pos | 8.93 | Neg | A1 | – | – | WHO stage I | |
ETH4500 | 30/F | Pos | Pos | 3.08 | Neg | D4 | – | – | WHO stage II | |
ETH1470 | 31/M | Pos | Pos | 0.48 | Neg | – | – | – | WHO stage I | |
ETH2590 | 38/F | Neg | Pos | Un | Neg | – | – | – | WHO stage I | |
ETH2570 | 46/M | Neg | Pos | Un | Neg | – | – | – | WHO stage I | |
ETH2150 | 49/F | Neg | Pos | Un | Neg | – | – | – | WHO stage I | |
CLD patients |
ETH4060
|
60/M
|
Neg
|
Neg
|
6.34
|
Neg
|
A1
|
3.01 × 10
5
|
I
|
Liver cirrhosis
|
ETH4100
|
33/M
|
Neg
|
Neg
|
3.15
|
Neg
|
A1
|
2.28 × 10
5
|
I
|
HCC
| |
ETH3020 | 21/F | Neg | Pos | 6.90 | Pos | A1 | – | – | ||
ETH3700 | 25/M | Neg | Neg | 7.60 | Pos | A1 | – | – | Liver ascites + cirrhosisa
| |
ETH4070 | 23/M | Neg | Neg | 4.04 | Neg | D3 | – | – | ||
ETH5730 | 45/M | Neg | Neg | 4.47 | Neg | D2 | – | – | Chronic hepatitisb
| |
ETH3080 | 38/F | Neg | Neg | 0.60 | Nd | – | – | – | Chronic hepatitisc
| |
ETH3120 | 64/M | Neg | Neg | 6.81 | Pos | A1 | – | – | ||
ETH3190 | 45/M | Neg | Neg | 1.56 | Neg | – | – | – | Chronic hepatitisd
| |
ETH3320 | 52/M | Neg | Neg | 1.00 | Nd | – | – | – | Liver cirrhosisa
| |
ETH3360 | 22/M | Neg | Neg | 0.78 | Neg | – | – | – | ||
ETH4390 | 27/M | Pos | Neg | 2.01 | Neg | – | – | – | ||
ETH4380 | 28/M | Pos | Neg | Un | Neg | – | 2.41 × 102
| – | Chronic hepatitise
| |
Blood donors |
ETH2056
|
47/M
|
Neg
|
Neg
|
8.39
|
Neg
|
D2
|
6.55 × 10
5
|
I
|
–
|
ETH5660 | 55/M | Neg | Neg | 0.78 | Nega
| – | – | – | – | |
ETH5650 | 38/M | Pos | Neg | Un | Nd | – | – | – | – |